Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Bibliographic Details
Main Authors:	Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S. Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-37338-7

Similar Items

Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up
by: Michal Canetti, et al.
Published: (2022-12-01)

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
by: Yaniv Lustig, et al.
Published: (2024-05-01)

Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years
by: Gili Joseph, et al.
Published: (2022-11-01)

Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study
by: Gili Joseph, et al.
Published: (2024-12-01)

Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study
by: Gili Joseph, et al.
Published: (2023-06-01)

SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response
by: Ili Margalit, et al.
Published: (2024-11-01)

High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients
by: Yana Davidov, et al.
Published: (2022-12-01)

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
by: Yana Davidov, et al.
Published: (2023-01-01)

Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
by: Mayan Gilboa, et al.
Published: (2023-09-01)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
by: Itzchak Levy, et al.
Published: (2022-07-01)

The Use of Rapid COVID-19 Antigen Test in the Emergency Department as a Decision-Support Tool
by: Lilac Meltzer, et al.
Published: (2023-01-01)

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season
by: Stephen Moss, et al.
Published: (2023-10-01)

Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy
by: Shlomi Toussia-Cohen, et al.
Published: (2022-11-01)

Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
by: Ravit Bassal, et al.
Published: (2022-10-01)

Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic
by: Ilana S. Fratty, et al.
Published: (2024-01-01)

Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory
by: Neta S. Zuckerman, et al.
Published: (2020-08-01)

A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel
by: Neta S. Zuckerman, et al.
Published: (2021-06-01)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018-10-01)

Highly Sensitive and Specific SARS-CoV-2 Serological Assay Using a Magnetic Modulation Biosensing System
by: Shira Avivi-Mintz, et al.
Published: (2021-12-01)

Possible Transmission of Pandemic (HIN1) 2009 Virus with Oseltamivir Resistance
by: Michal Mandelboim, et al.
Published: (2010-05-01)

Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity
by: Yaniv Lustig, et al.
Published: (2018-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
by: Shira Hirsh, et al.
Published: (2014-01-01)

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009–2014
by: Michal Chowers, et al.
Published: (2017-01-01)

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
by: Yaron Drori, et al.
Published: (2020-10-01)

MEVLÂNA CELÂLEDDİN RÛMÎ (1207-1273)
by: Sâfi Arpaguş
Published: (2007-12-01)

Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice
by: Tal Almog, et al.
Published: (2019-05-01)

Identification of Hepatitis E Virus Genotypes 3 and 7 in Israel: A Public Health Concern?
by: Rachel Shirazi, et al.
Published: (2021-11-01)

mRNA-1273 is placenta-permeable and immunogenic in the fetus
by: Jeng-Chang Chen, et al.
Published: (2025-03-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model
by: Nofar Atari, et al.
Published: (2023-04-01)

Motivations of Israeli physicians to return, or not, to Israel after their fellowship abroad
by: Lior Seluk, et al.
Published: (2024-11-01)

Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel.
by: Gili Regev-Yochay, et al.
Published: (2014-01-01)

Alans in the Southern Song campaign of Kaan and Emperor Khublai 1267–1273
by: Kaziev E.V.
Published: (2024-06-01)

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
by: Bethany Girard, et al.
Published: (2024-03-01)

Stability of beryllium-tungsten coatings under annealing up to 1273 K
by: R. Mateus, et al.
Published: (2024-03-01)

Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
by: Yoji Hoshina, et al.
Published: (2022-07-01)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
by: Szu-Ting Huang, et al.
Published: (2023-11-01)

β-Carotene from the Alga <i>Dunaliella bardawil</i> Decreases Gene Expression of Adipose Tissue Macrophage Recruitment Markers and Plasma Lipid Concentrations in Mice Fed a High-Fat Diet
by: Nir Melnikov, et al.
Published: (2022-06-01)

A Bibliometric Analysis of 25 Years and 1273 Dissertations in Thoracic and Cardiovascular Surgery
by: İsmail Sarbay
Published: (2024-12-01)

Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
by: Angel Shabu, et al.
Published: (2023-12-01)